Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBay Pharmaceuticals (NBY) Goodwill & Intangibles (2021 - 2023)

NovaBay Pharmaceuticals (NBY) has disclosed Goodwill & Intangibles for 3 consecutive years, with $348000.0 as the latest value for Q3 2023.

  • On a quarterly basis, Goodwill & Intangibles fell 92.27% to $348000.0 in Q3 2023 year-over-year; TTM through Sep 2023 was $348000.0, a 92.27% decrease, with the full-year FY2022 number at $2.6 million, down 72.99% from a year prior.
  • Goodwill & Intangibles was $348000.0 for Q3 2023 at NovaBay Pharmaceuticals, roughly flat from $348000.0 in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $9.7 million in Q4 2021 to a low of $348000.0 in Q2 2023.
  • A 3-year average of $3.6 million and a median of $3.6 million in 2022 define the central range for Goodwill & Intangibles.
  • Biggest YoY gain for Goodwill & Intangibles was 42.8% in 2023; the steepest drop was 92.27% in 2023.
  • NovaBay Pharmaceuticals' Goodwill & Intangibles stood at $9.7 million in 2021, then plummeted by 72.99% to $2.6 million in 2022, then crashed by 86.76% to $348000.0 in 2023.
  • Per Business Quant, the three most recent readings for NBY's Goodwill & Intangibles are $348000.0 (Q3 2023), $348000.0 (Q2 2023), and $2.6 million (Q1 2023).